Digital Diagnostics
About Digital Diagnostics
Digital Diagnostics is a pioneering healthcare AI company dedicated to transforming the quality, accessibility, equity, and affordability of global healthcare through the application of autonomous artificial intelligence in the medical diagnosis and treatment process. The company develops AI systems that can make clinical decisions without human intervention by analyzing high-quality medical images. [1, 14, 15, 21]
Their flagship product, LumineticsCore® (formerly IDx-DR), is the first FDA-cleared autonomous AI diagnostic system designed to detect diabetic retinopathy, including diabetic macular edema, at the point-of-care. [2, 6, 7, 14, 17] This technology aims to increase patient access to care by providing immediate diagnostic results and referring only those patients who require specialist follow-up, thereby reducing the need for additional appointments for many individuals. [14] Digital Diagnostics is also actively researching and developing AI-based diagnostic solutions for other conditions, including glaucoma, cardiovascular indications, age-related macular degeneration (AMD), and neurodegenerative indications. [24]
The company is committed to ethical AI development and works closely with healthcare industry stakeholders, including regulators, providers, and patient advocacy groups, to establish AI diagnosis as a new standard of care. [16, 21, 22] They have played a significant role in establishing industry firsts, such as the real-world clinical launch and EHR integration of an FDA-cleared autonomous diagnostic system, and the creation of the first autonomous AI CPT® category 1 code for billing and payment. [14, 22]
Focus Areas
Business Intelligence
| Key Investors | KKR, Cedar Pine, Kinderhook, 8VC, Optum Ventures, OSF Ventures, Gundersen Health System, Edward - Elmhurst Health Venture Capital, University of Iowa, Canaan |
| Partnerships | OSF HealthCare, Baxter International |
| Acquisitions | 3Derm |
| Technology | AI-based diagnostic platform, autonomous AI algorithms, biomarker-based approach, deep learning, computer vision for medical imaging, cloud-based clinical result platforms, EHR interoperability |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Digital Diagnostics' LumineticsCoreu00ae offers significant advantages. It automates the screening and diagnosis of diabetic retinopathy, reducing the burden on specialists and freeing up physician time, potentially mitigating burnout. The point-of-care diagnosis allows for immediate patient counseling and referral, closing care gaps for the large percentage of diabetic patients who miss annual eye exams. The system is reimbursable with CPT Code 92229 and helps improve quality measure performance. Its FDA clearance and rigorous validation ensure a reliable and ethically designed diagnostic tool that enhances patient access to crucial early detection, ultimately preventing vision loss.
Digital Diagnostics systems, including LumineticsCoreu00ae, are designed for customized workflow integration solutions and can integrate with Electronic Health Records (EHRs). This allows clinical staff to access results and patient information within a single workflow, enhancing efficiency and supporting timely follow-up and care coordination.
What the Web Says
Digital Diagnostics is a healthcare AI company focused on developing autonomous diagnostic systems, primarily for diabetic retinopathy. Their flagship product, LumineticsCoreu00ae, aims to increase access to care by providing rapid, point-of-care diagnoses without requiring a specialist review. The company is recognized for its pioneering work in establishing AI diagnosis as a standard of care and has received positive feedback for its innovative technology and potential to improve patient outcomes. However, employer reviews indicate some concerns regarding management and work culture.
Overall: MixedStrengths
- Pioneering AI in healthcare diagnostics, particularly with LumineticsCoreu00ae for diabetic retinopathy.
- Increases patient access to care by providing point-of-care diagnoses.
- Provides rapid diagnostic results, facilitating immediate care decisions.
- Enhances diagnostic accuracy and streamlines healthcare processes through AI.
- Strong focus on business ethics and building safe, accessible healthcare solutions.
- Positive impact on learning opportunities and efficiency in digital pathology.
Limitations
- Some employee reviews mention negative work culture.
- Upper management reportedly does not always understand quality regulations.
- Goals, objectives, and strategic decisions are frequently changing, leading to wasted effort.
- Potential for job losses in traditional roles due to AI integration.
- Product (IDx-DR/LumineticsCore) is less effective at detecting earlier stages of diabetic retinopathy.
- Images may not always be classifiable by the AI diagnostic system.
Based on reviews from: Indeed.com, Elion Health, BIS Research, Review of Optometry, Reddit, Digital Diagnostics Careers, Capterra
Last updated: 2026-07-20
Videos
News, demos, and interviews about Digital Diagnostics.
Videos load interactively. If none appear, search YouTube for Digital Diagnostics →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Digital Diagnostics.
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]